Savarese, Gianluigi
 Distribuzione geografica
Continente #
AS - Asia 1.012
NA - Nord America 646
EU - Europa 396
SA - Sud America 252
AF - Africa 26
Totale 2.332
Nazione #
US - Stati Uniti d'America 617
SG - Singapore 412
CN - Cina 230
BR - Brasile 216
HK - Hong Kong 154
IT - Italia 143
VN - Vietnam 73
DE - Germania 47
FR - Francia 41
RU - Federazione Russa 37
TR - Turchia 32
FI - Finlandia 27
GB - Regno Unito 24
IN - India 21
BD - Bangladesh 17
CA - Canada 16
IQ - Iraq 15
NL - Olanda 15
ES - Italia 12
SA - Arabia Saudita 12
AR - Argentina 11
AT - Austria 11
UA - Ucraina 11
PK - Pakistan 8
CO - Colombia 7
MX - Messico 7
PL - Polonia 7
MA - Marocco 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
JP - Giappone 5
VE - Venezuela 5
KE - Kenya 4
LT - Lituania 4
SE - Svezia 4
UZ - Uzbekistan 4
CL - Cile 3
EC - Ecuador 3
ID - Indonesia 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
IR - Iran 2
MG - Madagascar 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PT - Portogallo 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 2.332
Città #
Singapore 213
Hong Kong 154
Ashburn 87
San Jose 83
Beijing 69
The Dalles 68
Los Angeles 32
Lauterbourg 30
Dallas 29
Istanbul 27
Ho Chi Minh City 25
Milan 25
São Paulo 25
New York 24
Moscow 17
Romola 17
Hanoi 16
Buffalo 15
Munich 15
Lappeenranta 14
Santa Clara 14
Redondo Beach 13
San Francisco 12
Frankfurt am Main 11
Shanghai 11
Chennai 10
Chicago 10
Nuremberg 10
Rome 10
Orem 9
Turin 9
Atlanta 7
Da Nang 7
Guangzhou 7
Montreal 7
Rio de Janeiro 7
Amsterdam 6
Baghdad 6
Belo Horizonte 6
Council Bluffs 6
Denver 6
Helsinki 6
Turku 6
Warsaw 6
Brasília 5
Brooklyn 5
Charlotte 5
Boston 4
Dhaka 4
Erbil 4
Jeddah 4
London 4
Manchester 4
Nairobi 4
Naples 4
Stockholm 4
São Bernardo do Campo 4
Tokyo 4
Toronto 4
Vienna 4
West Jordan 4
Airola 3
Bari 3
Basra 3
Boardman 3
Brescia 3
Cagliari 3
Caracas 3
Contagem 3
Haiphong 3
Hangzhou 3
Itajaí 3
Johannesburg 3
Kyiv 3
Lahore 3
Manaus 3
Medellín 3
Medina 3
Montevideo 3
Piracicaba 3
Pittsburgh 3
Porto Alegre 3
Potsdam 3
Salvador 3
Serra 3
Sorocaba 3
Tashkent 3
Thái Bình 3
Zhengzhou 3
A Coruña 2
Angra dos Reis 2
Ankara 2
Araruama 2
Bagnoli del Trigno 2
Bernareggio 2
Bogotá 2
Bologna 2
Campinas 2
Can Tho 2
Carapicuíba 2
Totale 1.364
Nome #
2024 update in heart failure 144
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC 94
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 83
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 82
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC 82
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC 75
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 75
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry 72
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 71
Insights into the European heart failure epidemiology 70
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 69
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry 69
Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis 68
Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: an analysis from the Swedish Heart Failure Registry 67
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 67
Comprehensive Characterization of Non-Cardiac Comorbidities in Acute Heart Failure- an analysis of ESC-HFA EORP Heart Failure Long-Term Registry 66
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension 66
Efficacy of SGLT2-inhibitors across different definitions of heart failure with preserved ejection fraction 64
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 63
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC 62
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry 59
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) 59
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) 58
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 58
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 55
Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis 54
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry 54
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC 53
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 53
Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure 51
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: insight from the ESC-HFA EORP Heart Failure Long-Term Registry 49
Rationale and Design of the ESC Heart Failure III Registry - Implementation and Discovery 48
Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure 45
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice 43
Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions 43
Translating the 2021 ESC heart failure guideline recommendations in daily practice: Results from a heart failure survey. A scientific statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC 42
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 36
Totale 2.369
Categoria #
all - tutte 12.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 0 0 0 0 0 0 0 5
2023/2024195 3 8 4 7 16 2 11 8 46 10 38 42
2024/2025590 9 2 25 70 49 37 79 15 52 40 114 98
2025/20261.579 215 197 117 203 139 98 207 141 173 89 0 0
Totale 2.369